InicioPodcastsThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the BalanceThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the Balance19 de mayo de 2026 · 1 h 9 minReproducir episodioCompartir desde este puntoNotas del episodioJeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."Todos los episodios de The Long Run with Luke Timmerman